Cargando…
The impact of COVID-19 pandemic on technologic and process innovation in point-of-care diagnostics for sexually transmitted infections
The STI diagnostic landscape of FDA cleared tests for use at point-of-care (POC), as well as those emergency use authorized for COVID-19 are reviewed; some of these COVID-19 diagnostics may have platform potential as STI diagnostics. Finally, process innovation is described with self-collection and...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Canadian Society of Clinical Chemists. Published by Elsevier Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604101/ https://www.ncbi.nlm.nih.gov/pubmed/34808115 http://dx.doi.org/10.1016/j.clinbiochem.2021.11.003 |